Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Marquart

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1994
Pharmacology of N-[4-(4-morpholinylcarbonyl)benzoyl]-L-valyl-N- [3,3,4,4,4-pentafluoro-1-(1-methylethyl)-2-oxobutyl]-L-prolinamide (MDL 101,146): a potent orally active inhibitor of human neutrophil elastaseS L Durham, C M Hare, M R Angelastro, et al.
International Journal of Obstetric Anesthesia|November 28, 2018
Increasing body mass index and abdominal subcutaneous fat thickness are associated with increased skin-to-epidural space distance in pregnant womenV A Eley, A Chin, R Sekar, et al.
The British Journal of Dermatology|December 20, 2019
Skin cancer multiplicity in lung transplant recipients: a prospective population-based studyM Way, L Marquart, D C Chambers, et al.
Bioorganic & Medicinal Chemistry Letters|September 7, 1999
Hydroxyoxazolidines as alpha-aminoacetaldehye equivalents: novel inhibitors of calpainN P Peet, H O Kim, A L Marquart, et al.
Bioorganic & Medicinal Chemistry Letters|July 13, 2007
Anthranilamide inhibitors of factor XaDavid Mendel, Angela L Marquart, Sajan Joseph, et al.
Journal of Medicinal Chemistry|July 23, 2004
Substituted 3-imidazo[1,2-a]pyridin-3-yl- 4-(1,2,3,4-tetrahydro-[1,4]diazepino-[6,7,1-hi]indol-7-yl)pyrrole-2,5-diones as highly selective and potent inhibitors of glycogen synthase kinase-3Thomas A Engler, James R Henry, Sushant Malhotra, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1994
Pharmacology of N-[4-(4-morpholinylcarbonyl)benzoyl]-L-valyl-N- [3,3,4,4,4-pentafluoro-1-(1-methylethyl)-2-oxobutyl]-L-prolinamide (MDL 101,146): a potent orally active inhibitor of human neutrophil elastaseS L Durham, C M Hare, M R Angelastro, et al.
International Journal of Obstetric Anesthesia|November 28, 2018
Increasing body mass index and abdominal subcutaneous fat thickness are associated with increased skin-to-epidural space distance in pregnant womenV A Eley, A Chin, R Sekar, et al.
The British Journal of Dermatology|December 20, 2019
Skin cancer multiplicity in lung transplant recipients: a prospective population-based studyM Way, L Marquart, D C Chambers, et al.
Bioorganic & Medicinal Chemistry Letters|September 7, 1999
Hydroxyoxazolidines as alpha-aminoacetaldehye equivalents: novel inhibitors of calpainN P Peet, H O Kim, A L Marquart, et al.
Bioorganic & Medicinal Chemistry Letters|July 13, 2007
Anthranilamide inhibitors of factor XaDavid Mendel, Angela L Marquart, Sajan Joseph, et al.
Journal of Medicinal Chemistry|July 23, 2004
Substituted 3-imidazo[1,2-a]pyridin-3-yl- 4-(1,2,3,4-tetrahydro-[1,4]diazepino-[6,7,1-hi]indol-7-yl)pyrrole-2,5-diones as highly selective and potent inhibitors of glycogen synthase kinase-3Thomas A Engler, James R Henry, Sushant Malhotra, et al.
Pageof 3